Laboratory behind Vyjuvek says talks with Infarmed are on the right track

Krystal Biotech, the manufacturer of the Vyjuvek gel for epidermolysis bullosa, confirmed that its funding request submitted to Infarmed on 19 October is progressing well. The laboratory plans to submit the clinical dossier to the Portuguese regulator during the week of 9 November.
